Dominic Reynolds

Title: Innovations of Inventor Dominic Reynolds

Introduction

Dominic Reynolds is an innovative inventor based in the United States. He has made significant contributions to the field of pharmaceutical compounds, particularly in the development of crystalline forms of specific inhibitors.

Latest Patents

One of his notable patents is the "Crystalline Fgfr4 Inhibitor Compound And Uses Thereof." This patent includes a number of crystalline forms of N-(2-((6-(3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-methylureido)pyrimidin-4-yl)amino)-5-(4-ethylpiperazin-1-yl)phenyl)acrylamide. The patent details various crystalline forms, including a crystalline free base form, a crystalline monohydrochloride salt form, a crystalline dihydrochloride salt form, and a crystalline ethanesulfonate salt form. Additionally, methods of making and using these crystalline compounds are provided.

Career Highlights

Throughout his career, Dominic Reynolds has focused on the development of innovative compounds that have potential therapeutic applications. His work has contributed to advancements in the pharmaceutical industry, particularly in the area of targeted therapies.

Collaborations

Dominic has collaborated with notable colleagues, including George Moniz and Kristen Sanders. These collaborations have enhanced the research and development of his innovative compounds.

Conclusion

Dominic Reynolds is a dedicated inventor whose work in crystalline compounds showcases his commitment to advancing pharmaceutical science. His contributions are significant, and his innovative spirit continues to drive progress in the field.